BREEZE-AD-PEDS: First Data for Baricitinib in Childhood Eczema

The first pediatric trial of baricitinib for childhood eczema suggests that symptoms improve, and the safety profile is similar to that seen in adults.
Medscape Medical News

source https://www.medscape.com/viewarticle/981709?src=rss